Hungry Hippo Fairing Successfully Qualified: Rocket Lab Clears Significant Milestone on Path to First Neutron Launch

(NASDAQ:RKLB), LONG BEACH, Calif., Dec. 08, 2025 (GLOBE NEWSWIRE) — Rocket Lab Corporation (Nasdaq: RKLB) (“Rocket Lab” or “the Company”), a global leader in launch services and space systems, today announced the Neutron launch vehicle's innovative “Hungry Hippo” captive fairing has successfully completed qualification testing and is enroute to Virginia for Neutron's first launch. Dubbed […]

FG Nexus Further Enhances Governance and Appoints Scott D. Wollney as Lead Independent Director

(NasdaqGM:FGNX),(NasdaqGM:FGNXP),(Boerse Frankfurt – Freiverkehr:LU51), Charlotte, NC, Dec. 08, 2025 (GLOBE NEWSWIRE) — FG Nexus Inc. (Nasdaq: FGNX, FGNXP) (the “Company”), today announced the appointment of Scott D. Wollney as Lead Independent Director of the Company's Board of Directors. Mr. Wollney has served as a director of the Company for the past 10 years, and currently

Toll Brothers Reports FY 2025 Fourth Quarter Results

(NYSE:TOL), FORT WASHINGTON, Pa., Dec. 08, 2025 (GLOBE NEWSWIRE) — Toll Brothers, Inc. (NYSE:TOL) (TollBrothers.com), the nation's leading builder of luxury homes, today announced results for its fourth quarter ended October 31, 2025. FY 2025's Fourth Quarter Financial Highlights (Compared to FY 2024's Fourth Quarter): Net income was $446.7 million and earnings per diluted share

Exicure Presents Positive Topline Phase 2 Data for Burixafor in Multiple Myeloma at 2025 ASH Annual Meeting

(NASDAQ:XCUR), REDWOOD CITY, Calif., Dec. 08, 2025 (GLOBE NEWSWIRE) — Exicure, Inc. (Nasdaq: XCUR), a clinical-stage biotechnology company developing therapeutics for hematologic diseases, today announced positive results from its completed Phase 2 trial evaluating burixafor (GPC-100) in combination with propranolol and granulocyte colony-stimulating factor (G-CSF) for the mobilization of hematopoietic progenitor cells (HPCs) in patients

United Community Banks, Inc. Announces Extension of Share Repurchase Program

(NYSE:UCB),(NYSE:UCB-PI), GREENVILLE, S.C., Dec. 08, 2025 (GLOBE NEWSWIRE) — United Community Banks, Inc. (NYSE: UCB) (the “Company”) today announced that the Company's Board of Directors approved a common stock repurchase program, authorizing the repurchase of up to $100.0 million of its outstanding common stock on the open market, in privately negotiated transactions, or in any

Hungry Hippo Fairing Successfully Qualified: Rocket Lab Clears Significant Milestone on Path to First Neutron Launch

Hungry Hippo Fairing Successfully Qualified: Rocket Lab Clears Significant Milestone on Path to First Neutron Launch GlobeNewswire December 08, 2025 LONG BEACH, Calif., Dec. 08, 2025 (GLOBE NEWSWIRE) — Rocket Lab Corporation (Nasdaq: RKLB) (“Rocket Lab” or “the Company”), a global leader in launch services and space systems, today announced the Neutron launch vehicle's innovative

Toll Brothers Reports FY 2025 Fourth Quarter Results

Toll Brothers Reports FY 2025 Fourth Quarter Results GlobeNewswire December 08, 2025 FORT WASHINGTON, Pa., Dec. 08, 2025 (GLOBE NEWSWIRE) — Toll Brothers, Inc. (NYSE:TOL) (TollBrothers.com), the nation's leading builder of luxury homes, today announced results for its fourth quarter ended October 31, 2025. FY 2025's Fourth Quarter Financial Highlights (Compared to FY 2024's Fourth

FG Nexus Further Enhances Governance and Appoints Scott D. Wollney as Lead Independent Director

FG Nexus Further Enhances Governance and Appoints Scott D. Wollney as Lead Independent Director GlobeNewswire December 08, 2025 Charlotte, NC, Dec. 08, 2025 (GLOBE NEWSWIRE) — FG Nexus Inc. (Nasdaq: FGNX, FGNXP) (the “Company”), today announced the appointment of Scott D. Wollney as Lead Independent Director of the Company's Board of Directors. Mr. Wollney has

Exicure Presents Positive Topline Phase 2 Data for Burixafor in Multiple Myeloma at 2025 ASH Annual Meeting

Exicure Presents Positive Topline Phase 2 Data for Burixafor in Multiple Myeloma at 2025 ASH Annual Meeting GlobeNewswire December 08, 2025 REDWOOD CITY, Calif., Dec. 08, 2025 (GLOBE NEWSWIRE) — Exicure, Inc. (Nasdaq: XCUR), a clinical-stage biotechnology company developing therapeutics for hematologic diseases, today announced positive results from its completed Phase 2 trial evaluating burixafor

United Community Banks, Inc. Announces Extension of Share Repurchase Program

United Community Banks, Inc. Announces Extension of Share Repurchase Program GlobeNewswire December 08, 2025 GREENVILLE, S.C., Dec. 08, 2025 (GLOBE NEWSWIRE) — United Community Banks, Inc. (NYSE: UCB) (the “Company”) today announced that the Company's Board of Directors approved a common stock repurchase program, authorizing the repurchase of up to $100.0 million of its outstanding

Scroll to Top